Molecular imprinting within hydrogels.

NSF Program on Therapeutic and Diagnostic Devices, Purdue University, West Lafayette, IN 47907, USA.
Advanced Drug Delivery Reviews (Impact Factor: 12.89). 02/2002; 54(1):149-61. DOI: 10.1016/S0169-409X(01)00246-0
Source: PubMed

ABSTRACT Hydrogels have been used primarily in the pharmaceutical field as carriers for delivery of various drugs, peptides and proteins. These systems have included stimuli-responsive gels that exhibit reversible swelling behavior and hence can show modulated release in response to external stimuli such as pH, temperature, ionic strength, electric field, or specific analyte concentration gradients. The focus of this article is to review molecular imprinting within hydrogels and discuss recent efforts on analyte-responsive intelligent gels, specifically suggesting the possibility of utilizing molecular imprinting strategies to impart analyte specificity and responsiveness within these systems. Molecular imprinting is an emerging field that produces precise chemical architecture that can bind analytes and differentiate between similar molecules with enantiomeric resolution. On the forefront of imprinting gel systems are intelligent, stimuli-sensitive imprinted gels that modify their swelling behavior and in turn modulate their analyte binding abilities. We discuss the challenges creating an imprinting effect in hydrogels and the possibilities of using molecularly imprinted mechanisms within controlled release gels.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Molecular imprinting as a promising and facile separation technique has received much attention because of its high selectivity for target molecules. In this study, lysozyme molecularly imprinted polymers (Lys-MIPs) were successfully prepared by the entrapment method with lysozyme as the template molecule, acrylamide as the functional monomer and N,N-methylenebisacrylamide as the cross-linker. The removal of the template lysozyme from the molecularly imprinted polymers was investigated in detail by two methods. The synthesized Lys-MIPs were characterized by scanning electron microscopy and Fourier transform–infrared, and the adsorption capacity, selectivity and reproducibility of the Lys-MIPs were also evaluated. The maximum adsorption capacity reached 94.8 mg/g, which is twice that of nonmolecularly imprinted polymers, and satisfactory selectivity and reproducibility were achieved. Using the Lys-MIP column, lysozyme could be separated completely from egg white, with purity close to 100% and mass recovery of 98.2%. This illustrated that the synthesized Lys-MIPs had high specific recognition and selectivity to the template lysozyme when they were applied to a mixture of protein standards and a real sample. Copyright © 2014 John Wiley & Sons, Ltd.
    Biomedical Chromatography 06/2014; 28(6). · 1.95 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The figure shows that the imprinting efficiency of PP-g-PAM MIPs gradually decreased with the cycle times (from 3.30 to 2.56) and reached a stable value after three cycle times. The imprinting efficiency of PP-g-PAM MIPs was maintained at 76% of the initial value even after five cycles. However, the imprinting efficiency of BSA-imprinted PAM microspheres continually declined with increasing cycle times. After five cycle times, the imprinting effect almost disappeared. This result is probably due to the soft texture of gel microspheres, which cannot stabilize the shape of the binding sites. By contrast, the strength of PP-g-PAM MIPs was significantly improved and the shape of the binding sites was almost stabilized.
    Talanta 01/2014; 121:256–262. · 3.50 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Introduction: Most ophthalmic drugs are delivered through eye drops even though only about 1 - 5% of the drug reaches the target tissue and the patient compliance is not good. Drug-eluting contact lenses could significantly increase bioavailability, reduce side effects and improve patient compliance. Areas covered: Recent research on drug-eluting contact lenses has focused on increasing the release duration through molecular imprinting, dispersion of barriers or nanoparticles, increasing drug binding to the polymer, sandwiching a PLGA (poly[lactic-co-glycolic acid]) layer in a lens and developing novel materials. This review covers all these studies with a specific focus on the transport mechanisms and advantages and disadvantages of each approach. Expert opinion: The main reason for prior failures was the short duration of release from the lenses. The new technologies can provide extended drug release for hours to days. The in vivo animal and clinical studies have proven the safety and efficacy of drug-eluting contact lenses, while showing considerable improvements compared to eye drops. The future appears to be promising but several challenges remain such as processing and storage issues, regulatory hurdles, high costs of clinical studies, potential lack of acceptance by the elderly, etc.
    Expert Opinion on Drug Delivery 07/2013; · 4.87 Impact Factor


Available from